Amanote Research
Register
Sign In
Apoptosis Induced by an Anti-Epidermal Growth Factor Receptor Monoclonal Antibody in a Human Colorectal Carcinoma Cell Line and Its Delay by Insulin.
Journal of Clinical Investigation
- United States
doi 10.1172/jci117871
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Date
April 1, 1995
Authors
X Wu
Z Fan
H Masui
N Rosen
J Mendelsohn
Publisher
American Society for Clinical Investigation
Related search
Conversion of a Murine Monoclonal Antibody A13 Targeting Epidermal Growth Factor Receptor to a Human Monoclonal Antibody by Guided Selection
Experimental and Molecular Medicine
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Molecular Medicine
Increased Epidermal Growth Factor Receptor Gene Expression by Γ-Interferon in a Human Breast Carcinoma Cell Line
British Journal of Cancer
Cancer Research
Oncology
Construction of an Immunotoxin by Linking a Monoclonal Antibody Against the Human Epidermal Growth Factor Receptor and a Hemolytic Toxin
Biological Research
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Epidermal Growth Factor Receptor Activation by Epidermal Growth Factor Mediates Oxidant-Induced Goblet Cell Metaplasia in Human Airway Epithelium
American Journal of Respiratory Cell and Molecular Biology
Respiratory Medicine
Pulmonary
Clinical Biochemistry
Cell Biology
Molecular Biology
Cell Cycle Arrest Induced by Epidermal Growth Factor on Human Squamous Cell Carcinoma Cell Lines.
Kokubyo Gakkai zasshi. The Journal of the Stomatological Society, Japan
Medicine
Molecular Predictors of Response to a Humanized Anti-Insulin-Like Growth Factor-I Receptor Monoclonal Antibody in Breast and Colorectal Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Regulation of Androgen Receptor by Androgen and Epidermal Growth Factor in a Human Prostatic Cancer Cell Line, LNCaP.
Endocrinologia Japonica
Monoclonal Antibody Against Epidermal Growth Factor Receptor Is Internalized Without Stimulating Receptor Phosphorylation.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulin-Like Growth Factor I Receptor Monoclonal Antibody
Molecular Cancer Therapeutics
Cancer Research
Oncology